InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by NEWELL WILLIAM J, Chairman & CEO. Director active across 1 companies, notably Sutro Biopharma, INC.. Cumulatively, 8 disclosures have been published. Total volume traded: €71k. The latest transaction was disclosed on 14 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
€70,90010,000 shares@ €7.090.011% mcap100.0% of flow
Common Stock
SEC:0001209191-22-018969:0·
Ideal exit: 9 Dec 2022 (T+270)
18,750 shares
Common Stock
SEC:0001209191-22-016856:0·
013,750 shares0
Common Stock
SEC:0001209191-22-006128·
013,750 shares0
Common Stock
SEC:0001209191-22-006128:0·
026,091 shares0
Common Stock
SEC:0001209191-22-000329:0·
026,091 shares0
Common Stock
SEC:0001209191-22-000329·
0104,662 shares0
Common Stock
SEC:0001209191-21-057981·
0104,662 shares0
Common Stock
SEC:0001209191-21-057981:0·
8 of 8 declarations
About NEWELL WILLIAM J
William J. Newell is the CEO of Sutro Biopharma, Inc. He leads the company by overseeing its operations and developing strategies for innovation in the biopharmaceutical sector. His leadership is crucial for Sutro's growth.
